Literature DB >> 21262433

Thrombin generation tests.

Elisabetta Castoldi1, Jan Rosing.   

Abstract

The recent development of semi-automated methods has revived interest in the thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin after initiation of coagulation. The thrombin generation curve, which is characterised by a lag phase followed by the formation and subsequent inhibition of thrombin, reflects all three phases of coagulation (initiation, propagation and termination). However, the specific contribution of each coagulation factor or inhibitor to the assay outcome depends on the reaction conditions used (e.g. tissue factor concentration used to trigger coagulation, addition of thrombomodulin or activated protein C). Although several studies have shown a correlation between thrombin generation and the risk of bleeding or venous thrombosis, the application of thrombin generation assays to clinical decision-making is still hampered by standardisation problems. The present paper discusses these issues with particular reference to Calibrated Automated Thrombography.
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262433     DOI: 10.1016/S0049-3848(11)70007-X

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  32 in total

1.  Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation.

Authors:  Yesim Dargaud; Jean Yves Scoazec; Simone J H Wielders; Christine Trzeciak; Tilman M Hackeng; Claude Négrier; H Coenraad Hemker; Theo Lindhout; Elisabetta Castoldi
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

Review 2.  Thrombin generation and bleeding in cardiac surgery: a clinical narrative review.

Authors:  John Fitzgerald; Robert McMonnies; Aidan Sharkey; Peter L Gross; Keyvan Karkouti
Journal:  Can J Anaesth       Date:  2020-03-04       Impact factor: 5.063

3.  Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

Authors:  L B Harrington; B T Marck; K L Wiggins; B McKnight; S R Heckbert; N F Woods; A Z LaCroix; M Blondon; B M Psaty; F R Rosendaal; A M Matsumoto; N L Smith
Journal:  J Thromb Haemost       Date:  2017-01-08       Impact factor: 5.824

4.  A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.

Authors:  Victoria Candy; Hilary Whitworth; Julie Grabell; Lisa Thibeault; Lori Harpell; Mackenzie Bowman; David Good; Wilma M Hopman; Robert F Sidonio; Paula D James
Journal:  Blood Adv       Date:  2018-10-23

5.  Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.

Authors:  Lauren E Witter; Erika J Gruber; Fabian Z X Lean; Tracy Stokol
Journal:  Am J Vet Res       Date:  2017-01       Impact factor: 1.156

6.  Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

Authors:  S Koutroumpi; L Spiezia; N Albiger; M Barbot; M Bon; S Maggiolo; S Gavasso; P Simioni; A Frigo; F Mantero; C Scaroni
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

7.  Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation.

Authors:  Saartje Bloemen; H Coenraad Hemker; Raed Al Dieri
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

8.  Defining the boundaries of normal thrombin generation: investigations into hemostasis.

Authors:  Christopher M Danforth; Thomas Orfeo; Stephen J Everse; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

9.  Preliminary hemocompatibility assessment of an innovative material for blood contacting surfaces.

Authors:  Martina Todesco; Elena Pontara; Chunyan Cheng; Gino Gerosa; Vittorio Pengo; Andrea Bagno
Journal:  J Mater Sci Mater Med       Date:  2021-07-27       Impact factor: 3.896

10.  Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.

Authors:  Oliviero Olivieri; Nicola Martinelli; Marcello Baroni; Alessio Branchini; Domenico Girelli; Simonetta Friso; Francesca Pizzolo; Francesco Bernardi
Journal:  J Am Heart Assoc       Date:  2013-11-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.